ATRA vs DHI · rev $128.9M vs P/E 9.6, rev $34.25B
Atara Biotherapeutics Inc (ATRA) versus DR Horton Inc (DHI) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
DR Horton Inc (DHI) is a residential construction company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
ATRA currently screens at market cap $87.1M. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Not investment advice. Open the ATRA and DHI stock pages for the full models.
Not investment advice.